Annis Gardner Whiting Capital Advisors, LLC Repligen Corp Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 1,240 shares of RGEN stock, worth $169,867. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,240
Previous 1,240
-0.0%
Holding current value
$169,867
Previous $185 Million
3.28%
% of portfolio
0.05%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$978 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$699 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$232 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$211 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.6B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....